Financials data is unavailable for this security.
View more
Year on year NANO MRNA Co Ltd had revenues fall -32.98% from 202.19m to 135.51m, though the company grew net income from a loss of 1.31bn to a smaller loss of 780.00m.
Gross margin | 80.72% |
---|---|
Net profit margin | -1,575.81% |
Operating margin | -1,769.27% |
Return on assets | -16.13% |
---|---|
Return on equity | -23.97% |
Return on investment | -17.89% |
More ▼
Cash flow in JPYView more
In 2024, NANO MRNA Co Ltd increased its cash reserves by 20.29%, or 265.67m. Cash Flow from Investing totalled 793.01m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 585.08m for operations while cash generated from financing totalled 3.73m.
Cash flow per share | -11.64 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 43.30 |
---|---|
Tangible book value per share | 43.30 |
More ▼
Balance sheet in JPYView more
Current ratio | 8.17 |
---|---|
Quick ratio | 8.17 |
Total debt/total equity | 0.3627 |
---|---|
Total debt/total capital | 0.2662 |
More ▼